Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen Edge Medical CoFRA:R5Z -0.96%20 PS Ratio is 28.88 as of Aug. 14, 2026, which is 30% below its 10-year median of 41.14. GuruFocus rates FRA:R5Z with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Shenzhen Edge Medical Co ranks worse than 93.65% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Shenzhen Edge Medical Co's share price is €4.13.
Shenzhen Edge Medical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.14. Hence, Shenzhen Edge Medical Co's PS Ratio for today is 28.88.
Good Sign:
Shenzhen Edge Medical Co Ltd stock PS Ratio (=30.37) is close to 1-year low of 28.2.
The historical rank and industry rank for Shenzhen Edge Medical Co's PS Ratio or its related term are showing as below:
FRA:R5Z'
s PS Ratio Range Over the Past 10 Years
Min: 28.2 Med: 41.14 Max: 54.04
Current: 31.37
During the past 3 years, Shenzhen Edge Medical Co's highest PS Ratio was 54.04. The lowest was 28.20. And the median was 41.14.
FRA:R5Z's PS Ratio is ranked worse than 93.65% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 3.01
vs FRA:R5Z: 31.37
Shenzhen Edge Medical Co (FRA:R5Z) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Edge Medical Co PS Ratio Chart
Shenzhen Edge Medical Co Annual Data
Trend
Dec23
Dec24
Dec25
PS Ratio
0.00
0.00
0.00
Shenzhen Edge Medical Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
PS Ratio
0.00
0.00
0.00
0.00
0.00
FRA:R5Z vs ABT, SYK, MDT: PS Ratio Comparison
For the Medical Devices subindustry, Shenzhen Edge Medical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Edge Medical Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Edge Medical Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Shenzhen Edge Medical Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Shenzhen Edge Medical Co's Share Price of today is €4.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shenzhen Edge Medical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Shenzhen Edge Medical Co (FRA:R5Z) has a PS Ratio of 28.88 as of Aug. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shenzhen Edge Medical Co and its competitors. This is 30% below median its historical median of 41.14. Over the past decade, Shenzhen Edge Medical Co's PS Ratio has ranged from 28.20 to 54.04. According to the industry distribution chart, Shenzhen Edge Medical Co ranks #752 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 93.6%.
Is Shenzhen Edge Medical Co's PS Ratio too high?
Shenzhen Edge Medical Co's current PS Ratio of 28.88 is 30% below median its 10-year median of 41.14. Over the past 10 years, this metric has ranged from a low of 28.20 to a high of 54.04. The Medical Devices & Instruments industry median PS Ratio is 3.01. Shenzhen Edge Medical Co's value of 28.88 is 859.5% above this industry median. Based on the distribution chart, Shenzhen Edge Medical Co ranks #752 out of 803 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen Edge Medical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Edge Medical Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Edge Medical Co ranks #752 out of 803 companies for PS Ratio. This places Shenzhen Edge Medical Co in the lower half of its industry. The industry median PS Ratio is 3.01. Shenzhen Edge Medical Co's value of 28.88 is 859.5% above this benchmark. Historically, Shenzhen Edge Medical Co's own PS Ratio has ranged from 28.20 to 54.04 over the past decade. While the company's 10-year median is 41.14 vs. the industry median of 3.01, Shenzhen Edge Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 3.01, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Edge Medical Co's current PS Ratio of 28.88 is 859.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Shenzhen Edge Medical Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 3.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Edge Medical Co's current PS Ratio is 28.88, which is 30% below median its own 10-year median of 41.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Edge Medical Co stock overvalued right now?
Shenzhen Edge Medical Co (FRA:R5Z) has a current PS Ratio of 28.88. The current PS Ratio is 28.88, which is 30% below median its 10-year median of 41.14 and 859.5% above the Medical Devices & Instruments industry median of 3.01. Shenzhen Edge Medical Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Shenzhen Edge Medical Co (FRA:R5Z), the current PS Ratio is 28.88 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shenzhen Edge Medical Co Ltd is principally engaged in the designing, research and development, manufacturing and sale of surgical robots. It has a pipeline of three products and product candidates covering various models at different development stages to capture the market potential in surgical robots, including Edge Multi-Port Endoscopic Surgical Robot and Edge Single-Port Endoscopic Surgical Robot for MIS, as well as Edge Bronchoscope Robot for non-invasive surgery. The company derives revenue principally from the sales of surgical robot systems, instruments and accessories, and provision of services. Geographically, the maximum revenue is generated from the Chinese mainland, followed by Asia (other than Chinese Mainland), Europe, and Others.
20GF Score
Get the complete analysis for FRA:R5Z
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R5Z has been successfully added to your 
